Living in Your Body After Treatment

There is a version of the end of treatment that gets quietly assumed — by the people around you, sometimes by the system, and often by you — that goes something like this: once treatment is finished, the body begins to recover. The acute damage done in the service of getting rid of the cancer starts to heal. Things gradually return to something like they were. You get your hair back. Your energy returns. The side effects recede. The body you knew reasserts itself.

For some people, this is broadly how it goes.

But for many people, the body after treatment is not simply the body before treatment recovering. It is a different body. Not ruined — not remotely — but changed in ways that can be small or significant, temporary or lasting, expected or entirely without warning. Changed by surgery that altered structure. Changed by chemotherapy that affected nerves and muscles and the cardiovascular system. Changed by radiotherapy that left its mark on the tissue it passed through. Changed by hormone treatments that altered the internal chemical environment in ways whose consequences run for years.

And here is the thing that causes enormous unnecessary suffering: most of these changes are either not explained in advance, explained too briefly in a rushed appointment, or assumed to be things the patient simply knows about. So people are dealing with a body that feels and functions differently, without knowing what is temporary and what may not be, without knowing that many of these things are treatable, without knowing how to ask for the help that exists. And underneath all of it, every new sensation triggers the question that nobody says out loud to their clinical team but that everybody is asking privately, at every moment.

Is this the cancer again?

This chapter deals with the physical changes that happen after treatment, what can actually be done about them, and the question underneath all of them. It is not a complete clinical guide to every possible late effect. It is the honest, useful conversation that should have happened at the end of your last treatment appointment.

The question under every symptom

There is a specific quality to the experience of a new physical sensation after cancer treatment that is different from the experience of a new sensation before it. Before the diagnosis, an ache in your shoulder was an ache in your shoulder. After treatment, an ache in your shoulder goes through a different filter: it is evaluated, located, compared against what you remember, considered against the specific cancer type you had, measured against how it felt yesterday and the day before. This is not hypochondria. This is the nervous system doing the job that cancer treatment reassigned it — watching for threat. Chapter 2 described this at length because it is a psychological reality. It is worth addressing here as a physical one too, because it shapes the experience of every late effect in this chapter.

The honest answer to is this the cancer again, for the overwhelming majority of new sensations after treatment, is no. The body after cancer treatment is doing complex, slow, ongoing repair work, and that work produces a great deal of unfamiliar sensation. The late effects and long-term effects in this chapter are frequently odd, sometimes alarming, and in most cases the explanation is the treatment rather than the disease returning. Neuropathy. Muscle and joint changes from hormone therapy. Radiation fibrosis. The body reshaping itself around surgery. The immune system rebuilding. All of these produce sensations that can feel significant and that are, in the majority of cases, explicable by what the treatment did.

But some symptoms do require prompt attention, and there is a simple framework that is more useful than either blanket reassurance or constant alarm.

Any symptom that is new, that has been present for two weeks or more, and that is either not improving or is getting worse, deserves to be reported to your GP or clinical team. Not as a crisis. As information that needs assessment. The clinical team cannot distinguish between a treatment effect and something that needs investigation without knowing about it, and getting it assessed gives you an answer. Sitting with it unexamined while the fear builds is worse in every way than making the call.

There are symptoms that need same-day rather than routine contact: unexplained significant weight loss over a short period, a new lump that was not there before, blood in your urine or coughed up, significant rectal bleeding, severe headaches that feel different from your usual headaches, or anything specifically listed in your treatment summary as a warning sign. If you cannot find your treatment summary, ask your GP surgery for a copy of what was sent to them.

Everything else — the twinges, the joint aches, the tingling, the fatigue, the strange sensations that come and go — is much more likely to be explained by the sections below than by what you are afraid it might be.

Long-term effects and late effects — the difference matters

Before the specific conditions, this distinction is worth understanding because it changes how you interpret your experience.

Long-term effects are problems that begin during treatment and continue into survivorship. Fatigue and cognitive change, covered in Chapters 3 and 4, are the most common examples. They are ongoing from the treatment period into the months and years that follow.

Late effects are problems that develop or become apparent only after treatment has ended — sometimes months later, sometimes years later, sometimes decades later. They occur because the biological processes that treatment triggers continue to unfold long after the final session. Peripheral neuropathy, cardiovascular effects from certain chemotherapy drugs, bowel and bladder changes from pelvic radiotherapy, and bone density loss from hormone treatment can all emerge or worsen after treatment ends. This is why the period after treatment is not a straightforward recovery arc. Some things improve. Some persist. Some are only just beginning to make themselves known.

A large international review confirmed that late and long-term effects can continue to develop for up to 25 years after the initial diagnosis. This is stated not to alarm but to explain: the months and years after treatment are not simply the time during which you return to your previous body. They are a period of genuine biological change that warrants attention and engagement rather than waiting out.

Lymphoedema — the swelling that needs early attention

Lymphoedema is a persistent build-up of lymphatic fluid in the tissues, caused by damage to or removal of lymph nodes during surgery or radiotherapy. It produces swelling — most commonly in an arm after breast cancer treatment involving the lymph nodes, or in a leg after pelvic surgery or radiotherapy — along with a characteristic heaviness, tightness, and sometimes reduced mobility in the affected area. Around one in five breast cancer survivors develop arm lymphoedema, and rates vary by cancer type and treatment.

The critical thing to know about lymphoedema is that it does not resolve on its own, and it worsens if left untreated. The earlier it is identified and treated, the better the long-term outcome. If treatment is started promptly, many people achieve very good management of their symptoms. If it is left, it becomes harder to control.

What to watch for: persistent swelling in a limb that does not reduce with elevation or rest, a feeling of heaviness or aching in an arm or leg that wasn't there before, skin that feels thicker or firmer than usual, tightness when wearing a sleeve or trouser leg, or repeated skin infections in the same area.

If you notice any of these, contact your CNS or GP and use the words: I think I may have lymphoedema in my arm/leg and I would like a referral to a lymphoedema specialist. These are standard words that trigger the appropriate referral. Most NHS hospitals and cancer centres have lymphoedema services. You should not have to wait for a routine appointment to stretch over weeks — lymphoedema services accept referrals from GPs and CNSs, and the referral should be prompt.

Treatment involves a combination of specialist massage called manual lymphatic drainage, compression garments fitted to your specific measurements, skin care to prevent infection, and specific exercises. A lymphoedema nurse or physiotherapist will guide all of this. It is not something to manage alone from a leaflet.

One specific and urgent situation: if a limb affected by lymphoedema becomes hot, red, swollen, and painful — particularly if accompanied by any fever or feeling generally unwell — this may be cellulitis, a skin infection that people with lymphoedema are significantly more vulnerable to. Cellulitis needs same-day antibiotic treatment. Go to your GP or urgent care centre the same day. Untreated cellulitis in a lymphoedema-affected limb can become serious quickly.

Once seen by a specialist, there is also a self-help dimension to daily management. Gentle movement of the affected limb helps encourage drainage. Elevation when resting. Meticulous skin care using unscented moisturiser to prevent dryness and cracking, which creates infection entry points. Temperature extremes — very hot baths, sunburn — can worsen swelling. None of this replaces specialist assessment, but all of it matters day to day.

Peripheral neuropathy — the tingling, numbness, and what can be done

Chemotherapy-induced peripheral neuropathy — CIPN — is damage to the peripheral nerves caused by certain chemotherapy drugs. The most common culprits are taxanes (paclitaxel, docetaxel) and platinum compounds (oxaliplatin, cisplatin). It produces tingling, numbness, burning, or pain in the hands and feet that some people describe as wearing thick gloves or walking on gravel.

For many people, CIPN improves gradually as the nerves recover in the months after treatment ends. For some people — particularly those who had higher cumulative doses — it persists longer. For a smaller proportion, some degree of residual sensation change becomes a long-term feature of life after treatment. This is not a failure of recovery. It is a documented biological consequence of drugs that were needed.

What most people are not told is that there are things that can be done about it.

If the neuropathy involves significant pain — burning, shooting, or stabbing sensations — the medication with the best evidence for this is duloxetine. It is a prescription medication, and you need to ask your GP for it specifically. The words to use are: I have significant pain from chemotherapy-induced peripheral neuropathy and I have read that duloxetine has evidence for this — can we discuss whether it is appropriate for me? Your GP will know what you mean. Other medications including certain anticonvulsant drugs (pregabalin, gabapentin) may also be offered depending on your specific situation.

If the neuropathy affects your balance — if you feel uncertain on your feet, if steps or uneven surfaces are harder than they used to be — physiotherapy can help significantly. A physiotherapist can assess your balance and gait, teach you specific exercises, and advise on any practical adjustments that reduce fall risk. Ask your GP for a physiotherapy referral and mention the words balance problems from peripheral neuropathy.

Temperature perception: neuropathy can reduce the ability to feel whether something is dangerously hot or cold. Be cautious with very hot water — test it with a less-affected part of your body. Be careful with open fires, radiators, and ice packs applied directly to affected skin.

Fine motor skills: if buttons, fasteners, or keyboards are harder than they were, occupational therapy can help with both adaptive strategies and equipment. Ask your GP for an occupational therapy referral for chemotherapy-related neuropathy.

The joints, the bones, and hormone treatment

Aromatase inhibitors — anastrozole, letrozole, exemestane — are hormone treatments for hormone receptor-positive breast cancer, typically taken for five to ten years. They suppress oestrogen, which is the therapeutic goal. They also produce a well-documented set of physical effects that many people find significantly harder to manage than they were led to expect.

The most common is joint and muscle pain. Aching in the hands, wrists, knees, hips, and feet — often worst in the mornings and improving somewhat with movement through the day. This affects a substantial proportion of people on these drugs and in some people it is severe enough to affect daily life significantly. The important thing to know is that switching from one aromatase inhibitor to another often reduces the problem substantially. People who have severe joint pain on anastrozole may find letrozole more tolerable, or vice versa. If you are experiencing significant joint pain on an aromatase inhibitor and it has not been addressed, go back to your oncologist or GP and say specifically: my joint pain on this aromatase inhibitor is significantly affecting my daily life and I would like to discuss switching to a different one. This is a reasonable and well-documented clinical approach. Exercise — particularly weight-bearing activity — consistently reduces aromatase inhibitor-related joint pain in the evidence. The joints need movement, and less movement typically makes the pain worse.

The second effect is bone density loss. Oestrogen is protective for bones. Suppressing it through long-term aromatase inhibitor treatment accelerates bone density loss. Over a five to ten year treatment course this is clinically significant and requires management. Calcium and vitamin D supplementation, weight-bearing exercise, and regular DEXA scans to monitor bone density are the standard approach. If you are on a long-term aromatase inhibitor and have not had a DEXA scan, or have not been advised about calcium and vitamin D, ask your GP or oncologist specifically. The words are: I understand that aromatase inhibitors reduce bone density — can we discuss whether I should be having DEXA scans and whether I should be taking calcium and vitamin D?

Hormone treatment for prostate cancer — LHRH agonists such as goserelin, or anti-androgens — suppresses testosterone. The effects include hot flushes, fatigue, weight gain, mood changes, and significant bone density loss. Bone protection, monitoring, and discussion of these effects belongs with your oncology team. If these side effects are affecting your daily life and haven't been properly addressed, raise them directly — they are documented, expected, and manageable.

What nobody told you about your immune system

This question comes up constantly in cancer survivor communities and almost never gets a clear answer. People describe getting every cold going, every chest infection, every bout of flu seeming worse and lasting longer. They ask: is my immune system permanently damaged? And they rarely get a straight answer.

Here is the straight answer.

Chemotherapy attacks rapidly dividing cells throughout the body. The immune cells produced in the bone marrow divide rapidly. During treatment, the immune system is significantly suppressed. After treatment ends, it begins to rebuild. A University of Leeds study found that certain key immune cells — B cells and CD4 T cells — had recovered to only around 60–70% of their pre-treatment levels at nine months after treatment. That means that for the first several months after chemotherapy ends, the immune system is genuinely less capable than it was before, and vulnerability to infections is real and increased.

For most people, immune cell numbers rebound substantially within about a year of finishing treatment. The less simple news is that the full compositional complexity of the immune system may take longer to fully restore, and some research suggests certain immune changes persist for years.

In practical terms: being more susceptible to infections in the first year after chemotherapy is not in your imagination. It is a real and documented feature of the recovery period. Taking infections seriously during this time — not dismissing a chest infection as just a cold — is the appropriate response.

Vaccination is also relevant. If you missed routine vaccinations during treatment, your GP should be aware of this and can advise on when and what to re-offer. The annual flu vaccine and COVID boosters are particularly worth discussing.

What helps: gentle physical activity, which supports immune function. Adequate sleep, which is when the immune system does much of its work. Not smoking, which significantly impairs immune response.

If you are getting infections repeatedly or unusually severely — particularly chest infections, skin infections, or anything that requires antibiotics more than once in a few months — tell your GP and mention that you have recently completed chemotherapy. There are blood tests that can assess aspects of immune function and give a clearer picture.

What nobody told you about your teeth

Oral and dental effects of cancer treatment are one of the most consistently mentioned and consistently under-acknowledged late effects in survivor communities. People say: my teeth have fallen apart since treatment and nobody warned me.

For people who had radiotherapy to the head or neck, the salivary glands may have been in or near the radiation field. Saliva is not just lubrication — it is protective. It contains enzymes that neutralise the acids that bacteria produce on tooth surfaces. When the salivary glands are damaged by radiotherapy, saliva production is reduced (a condition called xerostomia, or dry mouth), and without that protection, tooth decay can develop much faster. If you had head or neck radiotherapy and are experiencing significant dry mouth, your GP or dentist can prescribe saliva substitutes and specific high-fluoride toothpaste. Dental check-ups should be more frequent — every six months rather than annually. Tell any new dentist specifically about your head or neck radiotherapy history, because it changes the risk picture and the management.

For people who had chemotherapy, effects are usually shorter-term — mouth sores during treatment, increased vulnerability to oral infections, and sometimes changes to enamel. These typically improve after treatment ends. However, if your teeth or gums have changed since chemotherapy in a way that persists, it is worth raising with your dentist. Mention the chemotherapy, the dates and drugs involved if you know them, and describe what has changed.

There is also a connection to bone health. For people on long-term bisphosphonate treatment (used to protect bones in breast and prostate cancer) or who had high-dose steroids as part of treatment, there is a small but real risk of a condition called osteonecrosis of the jaw if dental work is done — particularly extractions. This is why dentists need to know your cancer treatment history before doing any procedures. Tell them. Every time.

What nobody told you about your hearing

If you had cisplatin or carboplatin as part of your treatment — platinum-based chemotherapy drugs used for many cancers including testicular, ovarian, head and neck, and others — there is a specific and significant risk of hearing change that many people are not warned about.

Platinum-based drugs can cause damage to the hair cells of the inner ear, producing hearing loss and tinnitus — ringing or buzzing sounds. Research on testicular cancer survivors treated with cisplatin found that 74% reported some form of ototoxicity: 68% reported tinnitus and 59% reported hearing loss. These are not small numbers.

The damage tends to affect high-frequency hearing first. This means you may notice difficulty following conversations in noisy environments, difficulty hearing higher-pitched sounds, or a persistent ringing or hissing. Some people have significant difficulty at this frequency range without noticing it directly as hearing loss because normal conversational speech at quiet volumes is not yet affected.

This matters because hearing aids and management strategies can significantly improve quality of life even when the damage itself cannot be reversed. Tinnitus has its own evidence-based management approaches and its own support community.

If you had platinum-based chemotherapy and have noticed any of these changes, ask your GP for a referral to audiology. Use the words: I had cisplatin/carboplatin as part of my cancer treatment and I have noticed changes to my hearing and/or tinnitus. Audiologists understand platinum ototoxicity and can assess the extent of any hearing change and advise on management.

If you are not sure whether your chemotherapy regimen included platinum compounds, your treatment summary will say, or your GP surgery will have received documentation that includes it.

Pelvic radiation disease — the bowel and bladder changes that embarrass people into silence

Radiotherapy to the pelvis — used for cervical, uterine, endometrial, prostate, bladder, rectal, and anal cancers — can cause significant and lasting changes to the bowel and bladder. This is called pelvic radiation disease. Research confirms that 9 in 10 people who have had pelvic radiotherapy experience some degree of chronic side effects, and 1 in 2 experience significant changes to bowel function.

The bowel effects include: more frequent and urgent bowel movements, loose or liquid stools, difficulty controlling the bowel, rectal bleeding, and abdominal pain. The bladder effects include: urinary urgency, frequency, leakage, and blood in the urine.

These symptoms cause significant practical and social limitation. They also cause significant shame, because people don't discuss them. The result is that a very large number of people with pelvic radiation disease are managing it alone without the help that is available. This chapter is naming it directly because the silence around it is part of why it goes unmanaged.

Pelvic floor physiotherapy — which can be accessed via GP referral — can significantly improve both bowel and bladder symptoms. A specialist pelvic floor physiotherapist will assess what is happening and provide a tailored programme. For bladder urgency specifically, bladder training techniques can meaningfully reduce frequency and urgency over weeks.

For bowel symptoms, dietary changes and referral to a dietitian can help. Over-the-counter loperamide can help manage loose stools in the short term, but it is worth getting proper assessment rather than managing indefinitely with medication alone. Specialist gastroenterology review is available for complex bowel problems after pelvic radiotherapy — ask your GP and mention pelvic radiation disease specifically.

Bladder and Bowel UK have a national confidential helpline staffed by specialist nurses who can advise on management options and help you find your nearest continence service: 0161 214 4591. They are there for exactly this, and they are not surprised by anything. The Pelvic Radiation Disease Association has specific information and support at prda.org.uk.

Any blood in the urine or significant rectal bleeding should always be reported to your GP promptly. These may be radiation effects, but they require assessment to rule out other causes.

The menopause that treatment brought on

Treatment-induced menopause — from chemotherapy, ovarian suppression, surgical removal of the ovaries, or hormone treatment — deserves its own space because it arrives differently from natural menopause and often in a context where people already have limited reserve.

It tends to arrive suddenly rather than gradually. Hot flushes, night sweats, vaginal dryness, urinary changes, mood effects, joint aching, and reduced libido can be more abrupt and more intense than in natural menopause. And it arrives in the middle of cancer treatment and recovery, when there is already very little in reserve.

For those for whom HRT is not recommended — which includes many women with hormone receptor-positive breast cancer — non-hormonal options with evidence behind them include certain antidepressants (venlafaxine in particular has specific evidence for hot flushes), gabapentinoids, and CBT for menopause symptom management. In March 2026, NICE approved fezolinetant (Veoza), a new non-hormonal medication for moderate to severe hot flushes when HRT is not appropriate. It is not suitable for everyone — it is not recommended for those with current breast cancer, other oestrogen-dependent cancers, or liver disease — so this is a conversation to have with your GP or oncologist about what applies to your specific situation.

For vaginal dryness and urinary changes, vaginal moisturisers and lubricants — which are non-hormonal — can be significantly helpful. Low-dose vaginal oestrogen is considered safe for many women with a history of breast cancer, but this too needs to be discussed with your oncologist given your individual circumstances.

The Menopause and Cancer charity has UK-specific, cancer-context information about managing menopause after cancer treatment at menopauseandcancer.org. It is one of the more reliable and specific resources available for exactly this situation.

Cardiac effects — who needs to know

Certain chemotherapy drugs — specifically anthracyclines such as doxorubicin and epirubicin — carry a small but real risk of cardiac effects that can develop during or after treatment. If you received anthracycline-based chemotherapy and have since developed shortness of breath, reduced exercise tolerance, or swollen ankles, mention your anthracycline history explicitly to your GP. Trastuzumab (Herceptin) for HER2-positive breast cancer also has cardiac monitoring requirements during and after treatment — if you are not clear on your follow-up plan, ask your oncology team.

Radiotherapy to the chest — for breast cancer, lymphoma, or lung cancer — can affect the heart and lungs with effects that may appear years after treatment. If you had significant chest radiotherapy and notice increasing breathlessness over time, make sure any new GP who sees you knows this history.

What to do this week

If you develop sudden severe swelling in a limb, chest pain, significant new breathlessness, or blood in your urine or stools that is more than a trace — contact your GP same day or go to urgent care. Similarly, if a limb affected by lymphoedema becomes hot, red, painful, or you develop any fever — go to your GP or urgent treatment centre the same day for cellulitis assessment. Do not wait for a scheduled appointment with any of these symptoms.

• Macmillan on late effects — macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/late-effects
• Macmillan Support Line — free, 8am to 8pm, seven days (can post booklets to your home): 0808 808 00 00
• Bladder and Bowel UK helpline — specialist nurses, confidential: 0161 214 4591 — bbuk.org.uk
• Pelvic Radiation Disease Association — prda.org.uk
• Menopause and Cancer — UK-specific cancer-context information — menopauseandcancer.org
• Look Good Feel Better — free workshops for appearance changes after treatment — lgfb.co.uk
• Macmillan on lymphoedema — macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/lymphoedema